Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hidden liver danger in diabetes patients revealed

NCT ID NCT06445335

First seen Dec 04, 2025 · Last updated Apr 29, 2026 · Updated 22 times

Summary

This study aims to find out how many people with type 2 diabetes also have non-alcoholic fatty liver disease (NAFLD). Researchers will use a special ultrasound scan (FibroScan) to check the livers of 385 adults with type 2 diabetes. The goal is simply to measure how common this liver condition is in this group, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Ziekenhuis Oost-Limburg

    Genk, Limburg, 3600, Belgium

Conditions

Explore the condition pages connected to this study.